<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 307 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page306.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=307">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 307 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 307</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=307"><img src="../thumb/307.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>270 / 2020-04                                                            Anti-Microbials - 18.12
   Dosage: 1 tab.once dly.without regard to food.  Dosage: Herpes zoster: Adults: 250 mg 3xdly.x7 days. Init.within   (S4) TABS, 47/20.2.8/0232
   Contraindications: Safety & effic.not est.in hepatit. B vir.co-in-  72 hrs aft.rash onset.  720869-001: 30, R407,09
   fects., mod.to sev.uncontr. ren. impairm., pregn.& lactat., concom.  1st episode genital herpes: Within 72 hrs of appear.of sympts.   Dosage: 1 tab.once dly.without regard to food.
   cytidine analog. such as lamivudine/adefovir dipivoxil, concom.   250 mg 3xdly.x5 days.  Contraindications: Safety & effic.not est.in hepatit. B vir./HIV co-
   didanosine, safety & effic.in paed.pts. &lt;18 yrs.not est., concom.  Recurr.genital herpes: Within 6 hrs of sympts appear., 125 mg   infects.& paed.pts.&lt;18 yrs., pregn.& lactat., mod. to sev.ren.impairm.,
   atazanavir without ritonavir.  2xdly.x5 days.              creatin. clear. &lt; 30 ml/min, pts.req.haemodialys., concom. drugs con-
   Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.  Suppress.recurr.genital infects.in immunocompet. pts:   tain lamivudine/tenofovir/emtricitabine, safety & effic.in not est.
   incl.fatal., sev.ac.exacerbat.of hepatit. B aft.discont., headache,   125-250 mg 2xdly., length of treatm.dep.on sever. Re-eval.treatm.  Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.
   asthen., dizzin., sleep disturbs., depress., neuropathy, periph. neu-  aft.12 mnths.  incl.fatal., sev.ac.exacerbat.of hepatit. B aft.discont., ren.impairm.,
   rit., paraesthes., GI disturbs., rash, hyperpigmentat.of palms &/  Contraindications: Penciclovir hypersens., pregn. & lactat., not   ac.ren.fail.& Fanconi syndr., neutropen., haematuria, anaem., proxim.
   soles, arthralg., myalg., neutropen., anaem., incr.cough, rhinit., hy-  recom.in childr.as insuffic. data on safety & effic., no data in sev.  tubulopathy, allerg.reacts.incl.angioed., hyperglycaem., hypertri-
   perbilirubinaem., hypertriglyceridaem., hyperglycaem., pancreatit.,   hepat. impairm., lact.intol.  glyceridaem., hypophosphataem., hypokalaem, insomn., abnorm.
   abdom./back/chest pain, insomn., anx., pneumon., dyspn., hepatit.,   Side effects: Headache, thrombocytopen., N&V, confus./dizzin./  dreams, dizzin., neuropathy, periph.neuritis, paraesthes, headache,
   incr. liv.enzym./ser.amylase, hypophosphataem., ren. disords./im-  somnol.predomin.in elderly, hallucin., jaund., abnorm.LFT, skin reacts.  depress., GI disturbs., pancreatit, rais.liv.enzymes, hyperbilirubi-
   pairm.incl.ac.ren.fail., allergy, fev., sweat., weight loss, BMD decr.  incl. erythema multiforme/Stev.John.syndr.& tox. eipiderm. necrolys.  naem., hepatit., hepat.steatos., rash, prurit., urticar., skin discolourat.,
   from baseline, body fat redistribut./accumulat., cushingoid.appear.,   Warnings and special precautions: Imp.ren. funct., no inform. on   arthralg., myalg., creatine kinase elev., osteomalac., osteonecros.,
   fac. wasting, breast enlargem., inflamm.respons. to indol./resid.in-  pts.with overt.decompens. chron. liv.dis., not studied in ophthalm./  nephrogen.diab. insipid., nephrit., dyspn., pneum., chest/back pain,
   fects.necessit.furth.eval.& treatm., elev.creatin.kinase, haematur.  deseminat. zoster or in immunocomprom.pts., transmiss.risk of genit.   asthen., fev., sweat., weight loss, BMD decr., body fat redistrib./ac-
   Warnings and special precautions: No stud. demonstrat.eff.  herpes incr.dur.ac.episod., adeq protect.dur. intercourse  cumulat., cough, rhinit., anorex.
   on clinic.progress.of HIV-1, not recomm. as part of triple nucleoside   Drug interactions: Probenecid & other drugs that aff.ren.physiol.  Warnings and special precautions: Monit. hepat.funct.for sev.
   regim., obesity & prolong.nucleoside use poss.risk fact.for lact. aci-  could aff.plasma lev.  mnths.if discont.& pts.co-infect. with HIV & HBV, not recomm.as
   dos., liv.dis.risk fact., discont.if clin./lab. find. suggest.lact.acidos./  part of triple nucleoside regim., opportunist.infects.& HIV compli-
   pronounc.hepatotoxic., test for hepatit.B bef.init.ther., monit.hepat.  HEFTENAM, (Activo) Hetero, [P/S]  cat.may contin., prev.of risk of HIV transmiss. not proven, obesity
   funct. for sev.mnths.if discont.& pts.co-infect.with HIV & HBV, if ap-  Efavirenz 600 mg, emtricitabine 200 mg, tenofovir disoproxil fu-  & prolong. nucleoside use poss.risk fact.for lact.acidos., liv. dis.
   propr.init.of anti-HBV ther.may be warrant., imp.ren.funct., concom./  marate 300 mg.  risk fact., pancreatit., discont.if find.suggest. lact.acidos./ hepato-
   rec. nephrotox. agents, concom atazanavir be admin.with ritonavir,   Indications: Mono- or combinat.anti-retrovir. ther. for HIV-1 in-  toxic., test for hepatit.B bef. init. ther., imp.ren.funct., dos.interv.ad-
   monit. BMD in pts.with patholog.bone fract.hist./ at risk of osteo-  fect.in adults  justm. recomm. in creatin.clear.30 – 49 ml/min, calc. creat. clear.in
   pen., Ca & vit.D supplementat.poss benefic., elderly., developm.of   (S4) TABS, 46/20.2.8/0757  all pts.prior to init.ther.& as clinic. appropr. dur.ther., concom./rec.
   opportunist.infects. & other HIV complicat.may cont., ther.not prov.  721197-001: 30, R307,51  nephrotox.meds., recomm. concom.atazanavir be admin.with rito-
   to prev. HIV transmiss.risk, rare heredit probl./hist of galact. intol./  Dosage: Adults: 1 tab.once dly.on empty stomach. Bedt.dos.ti im-  navir, concom.didanosine & discont.if advers. effs. develop, monit.
   Lapp lact.defic./gluc.-galact. malabsorpt.  prov.CNS sympt.tolerabil.  BMD in pts.with patholog. bone fract.hist./at risk of osteopen, el-
   Interactions: Meds.that reduc.ren. funct./ compete for act. tubul.  Contraindications: Concom.astemizole/bepridil/ cisapride/mida-  derly, CV risk assessm. in pts.with evid.of lipodystroph., immune
   secret.poss.incr.ser.conc.of either med, C max of abacavir incr., AUC   zolam/pimozide/triazolam/ergot derivat/ St John’s Wort., concom.  reconstitut. syndr., lact.intol., concom.lopinavir/ ritonavir & discont.
   & C min of atazanavir decr., conc.incr.with atazanavir & lopinavir/ ri-  voriconazole, mod.-sev.ren.impairm., pregn.& lactat.  if advers.effs.develop
   tonavir, incr.tenofovir AUC & C min with darunavir/ritonavir combin,   Side effects: Lactic acidos.& sev.hepatomegaly with steatos.  Drug interactions: Ser.conc.incr.with concom. drugs elimin.by
   C max, AUC of didanosine incr.  incl.fatal., sev.ac.exacerbat.of hepatit B aft.discontinuat., ser.  act.tubul.secret., ser.conc.incr.by agents decr.ren.funct., atazanavir
                                psych.sympts.incl.sev. depress./ suicid.ideat./non fat.suicide at-
   ERIGE, Novagen [P/S]         tempts / aggress. behav./paranoid & manic reacts., CNS sympts.   & lopinavir /ritonavir incr.tenofovir conc., AUC & Cmin of atazanavir
                                                              decr., C max & AUC of didanosine incr., C max of lamivudine/indinavir
   Efavirenz.                   incl.hallucin./abnorm.think.& depersonalisat. which gen.improv.  decr., indinavir incr. tenofovir C max, abacavir C max incr.
   Indications: In combinat.with other antiretrovir. agents for HIV-1   with cont.ther., ren. impairm.incl.ac.ren.fail., skin rash, pain, GI
   infect.adults, adolesc.& childr. 13 kg & above and/ or 3 yrs and above.  disturbs., pancreatit., arthralg., back/chest pain, incr. cough, fev.,   HETERO TENOFOVIR, (Activo) Hetero [P/S]
   (S4) TABS, A40/20.2.8/0513   bld.dyscras., myalg., paraesthes., periph. neuropathy/-neurit.,   Tenofovir disoproxil fumarate
   710594-001: 600 mg, 30, R209,06  pneum., rhinit., hyperpigmentat. of palms &/soles, fatig., asth-  Indications: In combinat.with other antiretrovir.in adults with
   (S4) CAPS, 41/20.2.8/0541,0543  ma, URTI, influenza-like sympts., incr.lipid conc., palpitat., tinnit.,   HIV-1 infect.
   710592-001: 50 mg, 30, R47,79  vertigo, gynaecomast., libido chang., abnorm.vis., GI malabsorpt.,   (S4) TABS, 46/20.2.8/0019
   710593-001: 200 mg, 90, R256,14  hepatobil. disords., allerg.reacts., weight chang., body fat redis-  718284-001: 300 mg, 30, R283,77
   Dosage: Admin.in combinat.with a protease inhibit. and/or nu-  trib./ accumulat., myopathy, asthen., malaise, syncope, abnorm.  Dosage: 300 mg once dly.without regard to food.
   cleoside analog.revers. transcript. inhibit. Admin.on empty stom-  co-ordinat., atax., convuls., hypoaesthes., trem., dyspn., flush.,   Contraindications: Mod.-sev.ren.impairm., pregn. & lactat., safety
                      st
   ach.pref.at bedt. Bedt.dos.recomm.esp.dur.1  2-4 wks ther.& in   tachycard., erythema multiforme, Stev.-John.syndr., nail disords.,   & effic.in childr.und.18 yrs. not est., chron.HBV infect.,
   pts.exper. CNS effs.         photoallerg.dermatit., osteomalac., lumb. spine/hip & both arms   Side effects: Lactic.acidos.& sev.hepatomegaly with steatos.incl.
   Adults: Recomm.dos: 600 mg once dly. Adolesc. & childr.17 yrs.&   BMD decr.from baseline, convuls., inflamm.respons.to indolent/  fatal., sev.ac.exacerbat.of hepatit. B aft.discontinuat., ren.impairm.
   und: 600 mg at bedt. Use only in adults & childr.weigh.≥ 40 kg.  resid. infects. necessit.furth.eval.& treatm., alcoh.intol., hypophos-  incl.ac. ren. fail., mild to mod.GI effs., pancreatit., dizzin., headache,
   Concom.antiretrovir.ther: Must be giv.in combin. with other   phataem., hyperglycaem.  pain, fev., abdom./back/chest pain, asthen., osteonecros., lipodystro-
   antiretrovir.meds.           Warnings and special precautions: Chron.HBV infect., safety   phy, myopathy, musc. weakn., arthralg., myalg., depress., insomn.,
   Contraindications: Concom.terfenadine/ astemizole/ cisapride/  & effic. not est.in hepatit.B vir.co-infects., concom.meds/combinat.  periph. neuropathy, anx., pneum., neutropen., rash, sweat., weight
   midazolam/triazolam/ergot derivat.as ser./ life threat.adverse effs.  contain lamivudine, safety & effic. in pts.less than 18 yrs. not est.,   loss, allerg.reacts., hypophosphataem., dyspn., hepatit., hepatotox.,
   poss., pregn., breast feed.not recomm., childr.und.3 yrs./ weight &lt;   monit.hepat.funct.for sev.mnths.in pts.co-infect.with HIV & HBV &   hepat. steatos., ren.insuffic./-fail., BMD decr.from baseline, inflamm.
   13 kg, concom.St John’s Wort.  discont.ther., obesity & prolong. nucleoside use poss.risk fact.for lact.   respons.to indolent/resid. infects. necessit.furth.eval.& treatm.
   Side effects: Weight chang., CNS effs., dizzin., headache, con-  acidos., liv.dis. risk fact., discont.if find.suggest. lact.acidos./ hepa-  Warnings and special precautions: Safety & effic not est with
   vuls., hypoesthes., paraesthes., periph. neuropathy, tremor, psych.  totoxic., test for chron.hepatit.B bef.init.ther., immed.risk vs.benefit   hepatit.B (HBV) co-infect., monit. hepat. funct.for sev.mnths.in co-
   effs., speech disord., vertigo, neuralg., abnorm.vis., tinnit., flush.,   eval.of cont. ther. when ser.psych.sympts.exper., determ. creatin.   infect.HBV pts. who have discont.ther., obesity & prolong. nucleo-
   palpitat., tachycard., asthma, URTI, sinusit., dyspn., GI disords.  clear.bef.init.ther., avoid with concom./ rec.nephrotox.agents, pts at   side use poss.risk fact.for lact.acidos., liv. dis. risk fact., discont.
   incl.gastro-oesophag.refl., taste pervers., incr.appet., malabsorpt.,   risk of ren.impairm., pregn.test in women of childbear.age prior to   if find.suggest.lact.acidos./ hepatotoxic., no stud.demonstrat.eff.
   hepatit., hepat. fail., hepat.enzyme incr., skin reacts.incl.erythema   init. ther., barr.contracept.tog.with other methods recomm., elderly,   on clinic. progress. of HIV-1, imp.ren.funct., concom./rec. nephro-
   multiforme/ Stev.John.syndr., incr.sweat., alopec., nail disords.,   concom. didanosine/atazanavir/ lopinavir & discont.if advers.effs.  tox.meds., adjust.dos.interv.if creatinine clear. &lt;50 ml/min., test
   skin discolourat., arthralg./myalg., myopathy, impot., libido chang.,   develop, addit. ritonavir. recomm.with concom.fosamprenavir, do   for hepatit.B bef.init.ther., high rate of virolog.fail./resist.at early
   fatig., alcoh.intol., allerg.reacts., asthen., hot flush., flu-like sympts.,   not admin. concom.saquinavir as sole protease inhibit., monit.liv   stage when tenofovir combin.with lamivudine/abacavir as well as
   malaise, pain, syncope, body fat redistribut./ accumulat., rais.ser.  enzym.with concom.meds.assoc. with hepat.toxic./known or sus-  lamivudine/didanosine as once dly.regim., mitochrond. dysfunct.
   cholester./triglycerid.conc.  pect. HVB/C, no dos. recomm. for itraconazole avail.theref.seek alt.   in infts.expos.in utero/post natally theref.clinic.& lab.follow-up
   Special precautions: Teratogenicity in animals, use barrier con-  antifung., rash report.with efavirenz & clarithromycin theref.consid.  recomm., concom. didanosine/atazanavir/lopinavir & discont. if
   tracept.in combinat.with other methods, pregn. test in women of   alt.eg.azithromycin, combinat. with other macrolides not stud., monit.   advers.effs.develop,, recom.concom. atazanavir be admin.with
   childbear. potent. bef.init.ther., poss.pass.into breast milk, must not   BMD in pts.with patholog.bone fract.hist./at risk of osteopen., Ca &   ritonavir, monit.BMD in pts. with patholog.bone fract.hist./at risk
   be used as monother./add.on as sole agent to fail.regim., concom.  vit.D supplementat.poss benefic., seiz. hist., period.plasma monit.  of osteopen., immune reconstit.syndr., Ca & vit.D supplementat.
   indinavir, monit.liv. enzym.with retonavir, concom.methadone, ref.to   of anticonvuls. ther., discont.in case of sev.skin rash, weigh. benef.   poss benefic., elderly., opportunist. infects & other HIV compli-
   prod. lit.when prescrib.other meds., consid. simultan. discont.of all   vs risk in pts with persist.ser.transamin. elev. &gt;5xULN, immune re-  cat.still poss., ther.not proven to prev.HIV transmiss.through sex.
   antiretrovir.meds.if combinat. regim.is interrupt.because of suspect.   constit.syndr., opportunist. infects & other HIV complicat.still poss.,   cont./ bld.contam., rare heredit.galact.intol./Lapp lact. defic./
   intol.& restart medicat.at same time upon resolut. of intol. sympts.,   ther.not proven to prev.HIV transmiss. through sex.cont./bld.contam.,   gluc.-galact.malabsorpt.
   intermitt.monother./sequent. reintroduct. not advis., discont.in sev.  mitochrond. dysfunct. in HIV negat.infts.expos.in utero/post natally   Interactions: Ser.conc.of drugs elimin.by act. tubul. secret.may
   rash & consid. prophylax.with appropr.anthistam./ corticoster. for   theref.clinic.& lab.follow-up recomm.  incr., ser.conc.incr.by agents decr. ren.funct., C max & AUC of didano-
   mild to mod.rash to improv.tol.& resolv. rash, prev.ment.illn./subst.  Interactions: Reduc.NNRTI conc.with St John’s Wort expect., poss.  sine incr., AUC & C min of atazanavir decr., incr. AUC with lopinavir/
   abuse, be alert to psychos.-like reacts.& sev.ac.depress.reports, liv.   addit.CNS effs.with alcoh. /psychoact.meds., plasma conc.of other   ritonavir, incr.C max with indinavir, indinavir/ lamivudine C max decr.
   dis., monit.cholestrol./triglycerid./liv.enzym. esp.in known/ suspect.  compds. that are CYP3A4 substrat.poss.decr., meds.induc. CYP3A4
   hepatit. B/C infect.hist./ concom. liv. tox.assoc.meds.  activ.incr.clear., ser.conc.of drugs elimin. by act.tubul.secret.may incr.,   HETLAM, (Activo) Hetero [P/S]
   Drug interactions: Plasma conc.of other compds. that are CYP3A4   atazanavir conc.decr., atazanavir incr.tenofovir conc., amprenavir ser.   Lamivudine
   substrat.poss.decr., AUC & C max of indinavir/ saquinavir/clarithromy-  conc. decr., metabol.of indinavir incr., tenofovir conc. incr.with lopi-  Indications: Part of anti-retrovir.combinat.ther.of HIV infect.adults
                                                              & childr.&gt;12yrs.
   cin decr., incr. adverse effs.with ritonavir, rifampicin decr.AUC & C max,   navir/ritonavir combinat., lopinavir conc.decr., ritonavir & efavirenz   (S4) TABS, 43/20.2.8/0831
   methadone plasma lev.decr.& opiate withdr. signs, poss.reduc.conc.  conc. incr. with ritonavir, saquinavir conc.decr., didanosine conc.
   with St John’s Wort.         incr., warfar.plasma conc.incr. /decr., carbamazepine/phenytoin/  717806-001: 150 mg, 60, R149,62
                                phenobarbit.& efavirenz conc.decr.with concom use., sertraline/   Dosage: In combinat.with zidovudine as per P/I with/without food
   FAMVIR, (Sandoz) Novartis [P/S]  itraconazole/ ketoconazole/clarithromyc./ rifabutin/ Ca chan.block./  Adults & adolesc.over 12 yrs: 300 mg dly admin. as sngl.dly
   Famciclovir                  HMG-CoA reduct.inhibit. & methadone plasma conc.decr., rifampicin   dos OR 150 mg 2xdly.
   Indications: Herpes zoster (shingles) infect., 1st episode genit.  decr. efavirenz conc., ethinyl oestrad.conc.incr.  Contraindications: Concom.zalcitabine, safety in pregn.& lactat.
   Herpes within 72 hrs.of sympts, recurr.genit.Herpes within 6 hrs.  not est., limit.data in childr.und. 3 mnths., not suitable for pts. &lt; 50 kg
   of sympts, suppress.recurr.genital herpes in immunocompet. pts.  HETEMCIT, (Activo) Hetero [P/S]  Side effects: Lact.acidos.(mostly women) usually assoc.with sev
   (S4) TABS, 30/20.2.8/0277, 29/20.2.8/0189  Emtricitabine 200 mg, tenofovir disoproxil fumarate 300 mg  hepatomegaly & steatos. incl. fatalit., GI disturbs., pancreatit., bld.
   826715-001: 125 mg, 10, R158,46  Indications: In combinat.with other antiretrovir.in adults with HIV-  dyscras., skin rash, alopec., periph.neuropathy, paraesthes., head-
   815853-009: 250 mg, 21, R656,20  1 infect., pre-expos.prophylax. (PrEP) of HIV.  ache, depress./sleep disords., dizzin., musculoskelet. disords.incl.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page306.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page302.html">302</a>&nbsp;&nbsp;&nbsp;<a href="page303.html">303</a>&nbsp;&nbsp;&nbsp;<a href="page304.html">304</a>&nbsp;&nbsp;&nbsp;<a href="page305.html">305</a>&nbsp;&nbsp;&nbsp;<a href="page306.html">306</a>&nbsp;&nbsp;&nbsp;<a href="page307.html">307</a>&nbsp;&nbsp;&nbsp;<a href="page308.html">308</a>&nbsp;&nbsp;&nbsp;<a href="page309.html">309</a>&nbsp;&nbsp;&nbsp;<a href="page310.html">310</a>&nbsp;&nbsp;&nbsp;<a href="page311.html">311</a>&nbsp;&nbsp;&nbsp;<a href="page312.html">312</a>
             </td>
             <td width="35%"><a href="page308.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page308.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
